HK StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

LAEKNA-B

11.460

+0.1601.42%

Volume:1.25M

Turnover:14.44M

Market Cap:4.68B

PE:-15.16

High:11.960

Open:11.540

Low:11.220

Close:11.300

Loading ...

Overview Company News Filings

Laekna Begins Phase I Trial for Obesity Drug in China; Shares Jump 11%

MT Newswires Live

Laekna's 2024 Loss Narrows

MT Newswires Live

BRIEF-Laekna Inc Posts Loss For Year RMB254.3 Mln

Laekna Inc - Loss for Year RMB254.3 Mln

THOMSON REUTERS

Laekna, Inc.'s (HKG:2105) market cap dropped HK$392m last week; individual investors who hold 36% were hit as were institutions

Simply Wall St.

Laekna Successfully Completes Phase I Trial Of Obesity Drug

MT Newswires Live

Stock Track | Laekna Plummets 5.08% as Phase I Trial Update Fails to Impress Investors

Laekna Doses All Subjects in LAE102 Phase I Trial

MT Newswires Live

Laekna Obesity Drug Begins Clinical Study

MT Newswires Live

Stock Track | LAEKNA-B Soars 5.77% as Muscle Weakness Drug Study Commences

Laekna Starts Investigational New Drug-Enabling Study for Muscle Weakness Pill

MT Newswires Live

BUZZ-China's Laekna falls most in 7 months on discounted share sale

Laekna Seeks HK$230 Million in Placement Deal; Shares Fall 9%

MT Newswires Live

Stock Track | Laekna's Shares Plummet 10.94% on Plan to Place 17.6 Million New Shares

BRIEF-Laekna To Place Aggregate 17.6 MLN Shares At Hk$13.36 Per Share

Laekna Inc - Placing of New Shares

THOMSON REUTERS

China-based biotech Laekna teams up with Lilly to develop muscle preserving obesity drug

Laekna Inc - Lilly to Fund and Share Resources for Lae102 Development

THOMSON REUTERS

Laekna Announces a Clinical Collaboration With Lilly to Develop Lae102, a Novel Monoclonal Antibody Targeting Activin Receptor Type 2a for the Treatment of Obesity

THOMSON REUTERS

Laekna Inc - Retains Global Rights for Lae102

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/02105/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02105","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02105\",,,,,undefined,":{"symbol":"02105","market":"HK","secType":"STK","nameCN":"LAEKNA-B","latestPrice":11.46,"timestamp":1744877289031,"preClose":11.3,"halted":0,"volume":1247000,"delay":0,"floatShares":408000000,"shares":408000000,"eps":-0.7560241273067456,"marketStatus":"Closed Good Friday","change":0.16,"latestTime":"04-17 16:08:09","open":11.54,"high":11.96,"low":11.22,"amount":14435375,"amplitude":0.065487,"askPrice":11.52,"askSize":500,"bidPrice":11.46,"bidSize":1000,"shortable":0,"etf":0,"ttmEps":-0.7560241273067456,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1745285400000},"marketStatusCode":7,"adr":0,"listingDate":1687968000000,"exchange":"SEHK","adjPreClose":11.3,"openAndCloseTimeList":[[1744853400000,1744862400000],[1744866000000,1744876800000]],"volumeRatio":0.5022757481996416,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02105\",,,,,undefined,":{"symbol":"02105","floatShares":408000000,"roa":"-19.08%","roe":"-31.61%","lyrEps":-0.756024,"volumeRatio":0.5022757481996416,"shares":408000000,"dividePrice":0,"high":11.96,"amplitude":0.065487,"preClose":11.3,"low":11.22,"week52Low":3.9,"pbRate":"5.46","psRate":"8392.43","week52High":17.78,"institutionHeld":0,"latestPrice":11.46,"committee":0.333333,"eps":-0.7560241273067456,"divideRate":0,"volume":1247000,"delay":0,"ttmEps":-0.7560241273067456,"open":11.54,"prevYearClose":9.37,"prevWeekClose":10.64,"prevMonthClose":14.48,"prevQuarterClose":14.48,"fiveDayClose":9.32,"twentyDayClose":13.8,"sixtyDayClose":9.95},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02105\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2522731046","title":"Laekna Begins Phase I Trial for Obesity Drug in China; Shares Jump 11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2522731046","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522731046?lang=en_us&edition=fundamental","pubTime":"2025-03-27 15:21","pubTimestamp":1743060060,"startTime":"0","endTime":"0","summary":"Laekna  said it began recruitment for its Phase I multiple-ascending dose study in China for its obesity drug, with the first visit of the first subject completed, according to a filing with the Hong Kong bourse on Wednesday.LAE102 is a monoclonal antibody targeting ActRIIA, a receptor linked to muscle growth and fat metabolism, and has been shown to increase muscle and reduce fat in pre-clinical tests.The pharmaceutical's shares were up by about 11% in recent trading.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["02105","BK1161"],"gpt_icon":0},{"id":"2522020006","title":"Laekna's 2024 Loss Narrows","url":"https://stock-news.laohu8.com/highlight/detail?id=2522020006","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522020006?lang=en_us&edition=fundamental","pubTime":"2025-03-25 20:28","pubTimestamp":1742905739,"startTime":"0","endTime":"0","summary":"Laekna's  loss narrowed to 254.3 million yuan in 2024 from 368.8 million yuan in 2023, according to a Monday filing with the Hong Kong bourse.Loss per share at the drug company narrowed to 0.71 yuan from 1.68 yuan in the previous year.The company did not recognize revenue for the year.Other income increased to 38.2 million yuan from 16.7 million yuan in 2023.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["02105","BK1161"],"gpt_icon":0},{"id":"2521767877","title":"BRIEF-Laekna Inc Posts Loss For Year RMB254.3 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2521767877","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521767877?lang=en_us&edition=fundamental","pubTime":"2025-03-24 23:18","pubTimestamp":1742829527,"startTime":"0","endTime":"0","summary":"BRIEF-Laekna Inc Posts Loss For Year RMB254.3 MlnMarch 24 (Reuters) - Laekna Inc 2105.HK:LOSS FOR YEAR RMB254.3 MILLIONFurther company coverage: 2105.HK ((Reuters.Briefs@thomsonreuters.com;))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250324:nFWN3Q70WF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02105","BK1161"],"gpt_icon":0},{"id":"2521784097","title":"Laekna Inc - Loss for Year RMB254.3 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2521784097","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521784097?lang=en_us&edition=fundamental","pubTime":"2025-03-24 22:33","pubTimestamp":1742826820,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250324:nFWN3Q70WF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["02105","BK1161"],"gpt_icon":0},{"id":"2505004866","title":"Laekna, Inc.'s (HKG:2105) market cap dropped HK$392m last week; individual investors who hold 36% were hit as were institutions","url":"https://stock-news.laohu8.com/highlight/detail?id=2505004866","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505004866?lang=en_us&edition=fundamental","pubTime":"2025-01-24 06:52","pubTimestamp":1737672758,"startTime":"0","endTime":"0","summary":"Key Insights Significant control over Laekna by private equity firms implies that the general public has more power to...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2105/laekna-shares/news/laekna-incs-hkg2105-market-cap-dropped-hk392m-last-week-indi","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["02105","BK1161"],"gpt_icon":0},{"id":"2503314182","title":"Laekna Successfully Completes Phase I Trial Of Obesity Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2503314182","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503314182?lang=en_us&edition=fundamental","pubTime":"2025-01-13 09:50","pubTimestamp":1736733013,"startTime":"0","endTime":"0","summary":"Laekna  completed the phase I single ascending dose study  of LAE102 for treating obesity, according to a Monday filing with the Hong Kong bourse.Studies have been carried out in China and the US. LAE102 is a monoclonal antibody that specifically targets ActRIIA, a receptor involved in muscle regeneration and fat metabolism, the filing added.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1161","02105"],"gpt_icon":0},{"id":"1158586609","title":"Stock Track | Laekna Plummets 5.08% as Phase I Trial Update Fails to Impress Investors","url":"https://stock-news.laohu8.com/highlight/detail?id=1158586609","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1158586609?lang=en_us&edition=fundamental","pubTime":"2024-12-04 09:38","pubTimestamp":1733276302,"startTime":"0","endTime":"0","summary":"Laekna, a biotechnology company focused on developing innovative therapies, saw its stock price plummet 5.08% in Wednesday's intraday trading session. The decline comes despite the company's announcement regarding the progress of its phase I clinical trial for LAE102, a monoclonal antibody targeting ActRIIA.According to the company's filing with the Hong Kong stock exchange, the phase I trial is progressing effectively, with all 64 subjects across eight groups receiving intravenous and subcutane","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Stock Track | Laekna Plummets 5.08% as Phase I Trial Update Fails to Impress Investors","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["02105"],"gpt_icon":0},{"id":"2488909456","title":"Laekna Doses All Subjects in LAE102 Phase I Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2488909456","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488909456?lang=en_us&edition=fundamental","pubTime":"2024-12-04 08:24","pubTimestamp":1733271895,"startTime":"0","endTime":"0","summary":"Laekna  said the phase I clinical trial of LAE102 is progressing effectively, with all 64 subjects in eight groups receiving intravenous and subcutaneous injections of the single ascending dose study, according to a Wednesday filing with the Hong Kong bourse.LAE102 is a monoclonal antibody selectively targeting ActRIIA, a receptor essential in muscle regeneration and lipid metabolism, the filing said.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["02105","BK1161"],"gpt_icon":0},{"id":"2486399739","title":"Laekna Obesity Drug Begins Clinical Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2486399739","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486399739?lang=en_us&edition=fundamental","pubTime":"2024-11-28 18:31","pubTimestamp":1732789883,"startTime":"0","endTime":"0","summary":"Laekna  advanced its obesity drug LAE123 to pre-clinical candidate declaration and has commenced an IND-enabling study of the drug for treating severe diseases, according to a Wednesday filing with the Hong Kong bourse.LAE123 is a strong ActRIIA and ActRIIB blocker with superior potency in cell-based reporter gene assays  aimed at finding cures for severe diseases, such as pulmonary arterial hypertension and spinal muscular atrophy.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["RGA","02105","BK1161","BK4019"],"gpt_icon":0},{"id":"1171959242","title":"Stock Track | LAEKNA-B Soars 5.77% as Muscle Weakness Drug Study Commences","url":"https://stock-news.laohu8.com/highlight/detail?id=1171959242","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1171959242?lang=en_us&edition=fundamental","pubTime":"2024-11-28 10:14","pubTimestamp":1732760068,"startTime":"0","endTime":"0","summary":"Shares of LAEKNA-B, the biotech firm traded on the Hong Kong exchange, surged 5.77% in Thursday's intraday trading session. The stock's rally came after the company announced the commencement of an investigational new drug-enabling study for its muscle weakness treatment candidate LAE123.LAE123 is a novel drug that inhibits activin type II receptors ActRIIA/IIB, which play a key role in preventing sarcopenia or age-related muscle loss and weakness. By targeting these receptors, Laekna aims to de","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["02105"],"gpt_icon":0},{"id":"2486339400","title":"Laekna Starts Investigational New Drug-Enabling Study for Muscle Weakness Pill","url":"https://stock-news.laohu8.com/highlight/detail?id=2486339400","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486339400?lang=en_us&edition=fundamental","pubTime":"2024-11-28 10:09","pubTimestamp":1732759760,"startTime":"0","endTime":"0","summary":"Laekna  commenced its investigational new drug-enabling study for its LAE123 drug, according to a Thursday filing with the Hong Kong Exchange.LAE123 inhibits activin type II receptors or ActRIIA/IIB and helps prevent sarcopenia or muscle weakness.The company has advanced the drug to pre-clinical candidate declaration, the filing said.Price : $15.04, Change: $-0.22, Percent Change: -1.44%","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4526","BK4023","02105","BK4585","BK4588","HKD","BK1161"],"gpt_icon":0},{"id":"2485487566","title":"BUZZ-China's Laekna falls most in 7 months on discounted share sale","url":"https://stock-news.laohu8.com/highlight/detail?id=2485487566","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2485487566?lang=en_us&edition=fundamental","pubTime":"2024-11-21 12:30","pubTimestamp":1732163408,"startTime":"0","endTime":"0","summary":"** Shares of Chinese biotechnology firm Laekna    slump 14.9% to HK$13.38, on course for the biggest one-day pct drop since April 16    ** Stock third-biggest pct loser in Hang Seng Composite Index   , which slips 0.2%   ** Laekna plans to sell 17.64 mln new shares to raise HK$235.6 mln  for accelerating research and development of obesity drug LAE102 and other drug assets   ** New shares will be issued at HK$13.36 each, a 15.01% discount to Wednesday's close of HK$15.72 per share   ** Stock soared 48% on Wednesday after it entered into agreement with Eli Lilly    to develop an experimental obesity drug LAE102 to help patients lose weight while preserving muscle    ** Hang Seng Commerce & Industry Index    climbs 0.1%, healthcare index    adds 0.03%, while Hang Seng Index  slips 0.1%   ** Laekna shares down 29.4% YTD    ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1061106388.HKD","SG9999015952.SGD","LU1057294990.SGD","LU1712237335.SGD","LU0354030511.USD","LU0203202063.USD","SG9999018865.SGD","LU1551013425.SGD","LU2237443382.USD","LU0943347566.SGD","LU0061475181.USD","SG9999017495.SGD","GB00BDT5M118.USD","IE00BK4W5L77.USD","02105","LU0109391861.USD","LU2112291526.USD","LU2106854487.HKD","LU0238689110.USD","LU1988902786.USD","LU0114720955.EUR","SG9999014898.SGD","SGXZ51526630.SGD","IE0009355771.USD","LU0882574139.USD","LU0689472784.USD","LU2602419157.SGD","SG9999013999.USD","BK4585","LU1551013342.USD","LU2491049909.HKD","LU0079474960.USD","LU0471298777.SGD","LU1983299246.USD","LU1868836914.USD","BK1161","LU2237443465.HKD","LU2360106947.USD","BK4007","IE00B2B36J28.USD","LU0094547139.USD","LU2264538146.SGD","LU0385154629.USD","LLY","BK4533","LU0471298694.HKD","LU2324357040.USD","LU1093756325.SGD","BK4516","LU1974910355.USD"],"gpt_icon":1},{"id":"2485483748","title":"Laekna Seeks HK$230 Million in Placement Deal; Shares Fall 9%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485483748","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2485483748?lang=en_us&edition=fundamental","pubTime":"2024-11-21 10:34","pubTimestamp":1732156447,"startTime":"0","endTime":"0","summary":"Laekna  will sell 17,636,000 new shares to at least six investors under a placing deal, according to a Thursday filing with the Hong Kong Exchange.The biotechnology company will shell the shares at HK$13.36 apiece.The shares represent 4.33% of Laekna's issued share capital, as enlarged by the placement.Net proceeds, estimated at HK$230.3 million, will be used to speed up research for the company's LAE102 weight-loss drug, the filing stated.Shares slid 9% during Thursday's morning trading.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1161","02105"],"gpt_icon":0},{"id":"1116383768","title":"Stock Track | Laekna's Shares Plummet 10.94% on Plan to Place 17.6 Million New Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=1116383768","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1116383768?lang=en_us&edition=fundamental","pubTime":"2024-11-21 09:30","pubTimestamp":1732152644,"startTime":"0","endTime":"0","summary":"Laekna's stock  plummeted by 10.94% during Thursday's trading session, underperforming the broader market.The sharp decline came after the company announced plans to place an aggregate of 17.6 million new shares at HK$13.36 per share. This share placement could dilute existing shareholders' stakes and weigh on the stock price.","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Stock Track | Laekna's Shares Plummet 10.94% on Plan to Place 17.6 Million New Shares","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["02105"],"gpt_icon":0},{"id":"2485105086","title":"BRIEF-Laekna To Place Aggregate 17.6 MLN Shares At Hk$13.36 Per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2485105086","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2485105086?lang=en_us&edition=fundamental","pubTime":"2024-11-21 08:17","pubTimestamp":1732148243,"startTime":"0","endTime":"0","summary":"BRIEF-Laekna To Place Aggregate 17.6 MLN Shares At Hk$13.36 Per ShareNov 21 (Reuters) - Laekna 2105.HK:PLACING OF NEW SHARESTO PLACE AGGREGATE 17.6 MILLION SHARES AT HK$13.36 PER PLACING SHAREFurther company coverage: 2105.HK ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241121:nFWN3MR1BX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02105"],"gpt_icon":0},{"id":"2485510516","title":"Laekna Inc - Placing of New Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2485510516","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2485510516?lang=en_us&edition=fundamental","pubTime":"2024-11-21 08:14","pubTimestamp":1732148042,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241121:nFWN3MR1BX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1161","02105"],"gpt_icon":0},{"id":"2484148710","title":"China-based biotech Laekna teams up with Lilly to develop muscle preserving obesity drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2484148710","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484148710?lang=en_us&edition=fundamental","pubTime":"2024-11-20 23:07","pubTimestamp":1732115266,"startTime":"0","endTime":"0","summary":"China-based biotech Laekna teams up with Lilly to develop muscle preserving obesity drug Nov 20 (Reuters) - Eli Lilly LLY.N and Hong Kong-listed Laekna 2105.HK will collaborate to develop an experimen","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241120:nL4N3MR128:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0106261372.USD","LU1061106388.HKD","LU1868837136.USD","LU2063271972.USD","IE00BK4W5M84.HKD","02105","LU2237443895.HKD","LU0061475181.USD","IE0004445239.USD","LU0198837287.USD","LU2265009873.SGD","LU0385154629.USD","LU1064131342.USD","LU1366192091.USD","SG9999015986.USD","LU0079474960.USD","LU2491050154.USD","IE00B2B36J28.USD","LU0097036916.USD","LU1267930730.SGD","LU0417517546.SGD","SGXZ81514606.USD","SGXZ99366536.SGD","LU1712237335.SGD","LU2362541513.USD","LU1035775433.USD","LU0256863811.USD","LU1917777945.USD","LLY","SRRK","LU0238689110.USD","SG9999014898.SGD","LU1023059063.AUD","BK4007","LU2112291526.USD","LU1868836914.USD","LU1551013425.SGD","LU1814569148.SGD","LU2237443382.USD","LU0640476718.USD","REGN","SG9999001176.SGD","SGXZ31699556.SGD","SG9999001176.USD","LU0109394709.USD","LU2360106947.USD","LU2361044865.SGD","LU0882574055.USD","BK4588","LU0466842654.USD"],"gpt_icon":1},{"id":"2484148831","title":"Laekna Inc - Lilly to Fund and Share Resources for Lae102 Development","url":"https://stock-news.laohu8.com/highlight/detail?id=2484148831","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484148831?lang=en_us&edition=fundamental","pubTime":"2024-11-20 22:00","pubTimestamp":1732111227,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241120:nTUA8JSTS0:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1161","LU1804176565.USD","LU1623119135.USD","IE00B1BXHZ80.USD","IE0009355771.USD","LU1917777945.USD","LU0708995401.HKD","SG9999014906.USD","SG9999015952.SGD","LU2237443382.USD","LU0096364046.USD","LU0640476718.USD","LU2211815571.USD","SG9999014880.SGD","SG9999018857.SGD","LU2023250504.SGD","IE00BK4W5L77.USD","SGXZ31699556.SGD","LLY","LU1064131342.USD","LU2237438978.USD","LU0203201768.USD","LU1280957306.USD","LU1868837136.USD","LU0109391861.USD","LU1868836757.USD","02105","LU2360106947.USD","LU2468319806.SGD","LU2264538146.SGD","LU0238689110.USD","LU1712237335.SGD","LU0471298694.HKD","SGXZ99366536.SGD","LU0689472784.USD","IE00BJT1NW94.SGD","LU2461242641.AUD","IE00BJLML261.HKD","LU2089984988.USD","LU2361044865.SGD","LU2602419157.SGD","SG9999001176.SGD","LU1093756325.SGD","LU1023059063.AUD","SG9999017495.SGD","LU0943347566.SGD","BK4581","LU1061106388.HKD","LU0006306889.USD","LU2491050154.USD"],"gpt_icon":0},{"id":"2484110931","title":"Laekna Announces a Clinical Collaboration With Lilly to Develop Lae102, a Novel Monoclonal Antibody Targeting Activin Receptor Type 2a for the Treatment of Obesity","url":"https://stock-news.laohu8.com/highlight/detail?id=2484110931","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484110931?lang=en_us&edition=fundamental","pubTime":"2024-11-20 22:00","pubTimestamp":1732111227,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241120:nTUA8JSTS0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1161","02105"],"gpt_icon":0},{"id":"2484110071","title":"Laekna Inc - Retains Global Rights for Lae102","url":"https://stock-news.laohu8.com/highlight/detail?id=2484110071","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484110071?lang=en_us&edition=fundamental","pubTime":"2024-11-20 22:00","pubTimestamp":1732111227,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241120:nTUA8JSTS0:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1712237335.SGD","SG9999015952.SGD","SG9999014906.USD","IE00BJT1NW94.SGD","LU2237438978.USD","LU0109391861.USD","LU0238689110.USD","LU2264538146.SGD","LU2361044865.SGD","LU1064131342.USD","SG9999014880.SGD","IE00BJLML261.HKD","LU0943347566.SGD","LU1623119135.USD","LU1023059063.AUD","02105","SGXZ31699556.SGD","LU1061106388.HKD","LU2237443382.USD","LU2211815571.USD","SG9999001176.SGD","LU0096364046.USD","LU1868836757.USD","LU2602419157.SGD","LU0689472784.USD","LU0203201768.USD","LU2468319806.SGD","LU2461242641.AUD","BK1161","LU0708995401.HKD","IE00B1BXHZ80.USD","LU1804176565.USD","IE0009355771.USD","LU0006306889.USD","LU2023250504.SGD","LU2089984988.USD","SGXZ99366536.SGD","LLY","LU1093756325.SGD","LU0471298694.HKD","IE00BK4W5L77.USD","LU1868837136.USD","LU0640476718.USD","LU1280957306.USD","LU1917777945.USD","LU2360106947.USD","SG9999017495.SGD","BK4581","LU2491050154.USD","SG9999018857.SGD"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":26,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02105\",params:#limit:5,,,undefined,":[{"date":"2025-03-24","symbol":"02105","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1742779800000,"name":null,"time":"Post Market","dateTimestamp":1742745600000,"actualEps":null},{"date":"2024-08-16","symbol":"02105","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1723771800000,"name":null,"time":"Post Market","dateTimestamp":1723737600000,"actualEps":null},{"date":"2024-03-26","symbol":"02105","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1711416600000,"name":null,"time":"","dateTimestamp":1711382400000,"actualEps":null},{"date":"2023-08-24","symbol":"02105","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1692840600000,"name":null,"time":"","dateTimestamp":1692806400000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02105\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02105\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02105\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02105","date":"2025-04-17","current":-15.831036,"percent":0.067265,"low":-20.235293,"twenty":-11.83884,"median":-7.042573,"eighty":-4.481028,"high":-1.640852,"avg":-8.190906,"sd":4.277952,"marketCap":4281657466},"quantilePoints":[{"date":"2023-06-30","current":-7.785551,"twenty":-6.73679,"median":-5.163648,"eighty":-3.590506,"marketCap":6577091901},{"date":"2023-07-07","current":-6.912426,"twenty":-7.480081,"median":-7.023469,"eighty":-6.753459,"marketCap":5828099229},{"date":"2023-07-14","current":-6.415246,"twenty":-7.354402,"median":-6.80281,"eighty":-6.620389,"marketCap":5484810921},{"date":"2023-07-21","current":-6.50021,"twenty":-7.00126,"median":-6.637911,"eighty":-6.415921,"marketCap":5531622963},{"date":"2023-07-28","current":-6.387862,"twenty":-6.910347,"median":-6.626959,"eighty":-6.393338,"marketCap":5430196872},{"date":"2023-08-04","current":-6.872048,"twenty":-6.916775,"median":-6.645885,"eighty":-6.415921,"marketCap":5851505250},{"date":"2023-08-11","current":-8.062915,"twenty":-7.354402,"median":-6.732662,"eighty":-6.423028,"marketCap":6826756125},{"date":"2023-08-18","current":-6.496848,"twenty":-7.428921,"median":-6.729682,"eighty":-6.45189,"marketCap":5461404900},{"date":"2023-08-25","current":-8.440637,"twenty":-7.525288,"median":-6.804775,"eighty":-6.49752,"marketCap":6327427677},{"date":"2023-09-01","current":-9.089804,"twenty":-8.007442,"median":-6.902032,"eighty":-6.501491,"marketCap":6842360139},{"date":"2023-09-08","current":-6.586545,"twenty":-8.136633,"median":-6.907229,"eighty":-6.507456,"marketCap":4899660396},{"date":"2023-09-15","current":-5.932237,"twenty":-8.007442,"median":-6.869978,"eighty":-6.423028,"marketCap":4447143990},{"date":"2023-09-22","current":-6.606383,"twenty":-7.784235,"median":-6.883282,"eighty":-6.45189,"marketCap":4930868424},{"date":"2023-09-29","current":-7.14814,"twenty":-7.744431,"median":-6.894516,"eighty":-6.45189,"marketCap":5344374795},{"date":"2023-10-06","current":-7.631816,"twenty":-7.631816,"median":-6.912426,"eighty":-6.496848,"marketCap":5703267117},{"date":"2023-10-13","current":-8.856112,"twenty":-8.155063,"median":-6.923868,"eighty":-6.50021,"marketCap":6608299929},{"date":"2023-10-20","current":-8.199572,"twenty":-8.313082,"median":-7.000277,"eighty":-6.506614,"marketCap":6108971481},{"date":"2023-10-27","current":-9.816471,"twenty":-8.453817,"median":-7.029823,"eighty":-6.509983,"marketCap":7310480559},{"date":"2023-11-03","current":-11.65035,"twenty":-8.539495,"median":-7.190868,"eighty":-6.562195,"marketCap":8699237805},{"date":"2023-11-10","current":-10.973476,"twenty":-8.805599,"median":-7.285091,"eighty":-6.584244,"marketCap":8192107350},{"date":"2023-11-17","current":-11.729885,"twenty":-9.08956,"median":-7.4166,"eighty":-6.600627,"marketCap":8835772927},{"date":"2023-11-24","current":-11.685472,"twenty":-9.394133,"median":-7.490817,"eighty":-6.605936,"marketCap":8874782962},{"date":"2023-12-01","current":-9.84176,"twenty":-10.15546,"median":-7.577915,"eighty":-6.610422,"marketCap":7505530734},{"date":"2023-12-08","current":-7.796477,"twenty":-9.900606,"median":-7.778973,"eighty":-6.615093,"marketCap":5921723313},{"date":"2023-12-15","current":-9.518573,"twenty":-9.821529,"median":-7.782262,"eighty":-6.63353,"marketCap":7271470524},{"date":"2023-12-22","current":-9.095699,"twenty":-9.838318,"median":-7.864399,"eighty":-6.64429,"marketCap":6943786230},{"date":"2023-12-29","current":-10.114857,"twenty":-10.007865,"median":-8.108989,"eighty":-6.673018,"marketCap":7762996965},{"date":"2024-01-05","current":-7.064143,"twenty":-9.846254,"median":-7.963657,"eighty":-6.71691,"marketCap":5383384830},{"date":"2024-01-12","current":-6.507833,"twenty":-9.8409,"median":-7.785551,"eighty":-6.71691,"marketCap":4962076452},{"date":"2024-01-19","current":-6.147909,"twenty":-9.833261,"median":-7.674627,"eighty":-6.639506,"marketCap":4681204200},{"date":"2024-01-26","current":-4.037471,"twenty":-9.789285,"median":-7.606263,"eighty":-6.604594,"marketCap":3062287747},{"date":"2024-02-02","current":-1.910591,"twenty":-9.668744,"median":-7.523229,"eighty":-6.508431,"marketCap":1447272298},{"date":"2024-02-09","current":-1.972972,"twenty":-9.600955,"median":-7.449769,"eighty":-6.45189,"marketCap":1501886347},{"date":"2024-02-16","current":-2.11088,"twenty":-9.539168,"median":-7.4166,"eighty":-6.417948,"marketCap":1607213442},{"date":"2024-02-23","current":-1.782124,"twenty":-9.334553,"median":-7.285091,"eighty":-6.285716,"marketCap":1349747211},{"date":"2024-03-01","current":-3.73704,"twenty":-9.184661,"median":-7.220535,"eighty":-6.16588,"marketCap":2832128541},{"date":"2024-03-08","current":-3.812556,"twenty":-9.158571,"median":-7.14814,"eighty":-5.783471,"marketCap":2890643593},{"date":"2024-03-15","current":-3.774736,"twenty":-9.108268,"median":-7.054895,"eighty":-5.122231,"marketCap":2859435565},{"date":"2024-03-22","current":-3.314294,"twenty":-9.090983,"median":-7.029823,"eighty":-4.16949,"marketCap":2508345250},{"date":"2024-03-28","current":-5.557677,"twenty":-9.089621,"median":-7.000277,"eighty":-4.108477,"marketCap":2219670991},{"date":"2024-04-05","current":-4.994454,"twenty":-9.061533,"median":-6.958518,"eighty":-4.159233,"marketCap":1993412788},{"date":"2024-04-12","current":-4.698569,"twenty":-8.939101,"median":-6.914215,"eighty":-4.187247,"marketCap":1876382683},{"date":"2024-04-19","current":-5.074098,"twenty":-8.895252,"median":-6.907229,"eighty":-4.270544,"marketCap":2024620816},{"date":"2024-04-26","current":-6.049449,"twenty":-8.886537,"median":-6.872048,"eighty":-4.439166,"marketCap":2410820163},{"date":"2024-05-03","current":-6.122202,"twenty":-8.8768,"median":-6.815159,"eighty":-4.698569,"marketCap":2438127187},{"date":"2024-05-10","current":-6.43996,"twenty":-8.86224,"median":-6.755587,"eighty":-4.994454,"marketCap":2570761306},{"date":"2024-05-17","current":-7.203002,"twenty":-8.857338,"median":-6.782134,"eighty":-5.0499,"marketCap":2871138576},{"date":"2024-05-24","current":-4.794357,"twenty":-8.851703,"median":-6.739573,"eighty":-4.885401,"marketCap":2754108471},{"date":"2024-05-31","current":-4.572395,"twenty":-8.804497,"median":-6.721699,"eighty":-4.757241,"marketCap":2629276359},{"date":"2024-06-07","current":-4.421848,"twenty":-8.685949,"median":-6.645885,"eighty":-4.615745,"marketCap":2539553278},{"date":"2024-06-14","current":-3.882014,"twenty":-8.64394,"median":-6.616008,"eighty":-4.537135,"marketCap":2227472998},{"date":"2024-06-21","current":-3.862906,"twenty":-8.598267,"median":-6.605265,"eighty":-4.402835,"marketCap":2211868984},{"date":"2024-06-28","current":-3.550986,"twenty":-8.56584,"median":-6.575038,"eighty":-4.108477,"marketCap":2032422823},{"date":"2024-07-05","current":-3.292704,"twenty":-8.553381,"median":-6.507833,"eighty":-3.906941,"marketCap":1884184690},{"date":"2024-07-12","current":-3.669077,"twenty":-8.541472,"median":-6.498529,"eighty":-3.863311,"marketCap":2102640886},{"date":"2024-07-19","current":-2.927038,"twenty":-8.530589,"median":-6.44065,"eighty":-3.81922,"marketCap":1677431505},{"date":"2024-07-26","current":-2.773786,"twenty":-8.516747,"median":-6.41868,"eighty":-3.760814,"marketCap":1595510431},{"date":"2024-08-02","current":-3.12148,"twenty":-8.510893,"median":-6.387862,"eighty":-3.652511,"marketCap":1794461610},{"date":"2024-08-09","current":-2.9997,"twenty":-8.480176,"median":-6.325017,"eighty":-3.53511,"marketCap":1735946557},{"date":"2024-08-16","current":-3.214159,"twenty":-8.413826,"median":-6.28512,"eighty":-3.427,"marketCap":1860778669},{"date":"2024-08-23","current":-6.604067,"twenty":-8.372166,"median":-6.272718,"eighty":-3.478589,"marketCap":2129947911},{"date":"2024-08-30","current":-6.163541,"twenty":-8.347233,"median":-6.28512,"eighty":-3.497821,"marketCap":2001214795},{"date":"2024-09-06","current":-5.314921,"twenty":-8.300967,"median":-6.252611,"eighty":-3.516857,"marketCap":1726510663},{"date":"2024-09-13","current":-5.032211,"twenty":-8.277822,"median":-6.194778,"eighty":-3.53511,"marketCap":1630395636},{"date":"2024-09-20","current":-5.111432,"twenty":-8.256206,"median":-6.170373,"eighty":-3.56099,"marketCap":1665993794},{"date":"2024-09-27","current":-6.057967,"twenty":-8.195708,"median":-6.135055,"eighty":-3.605108,"marketCap":1986377216},{"date":"2024-10-04","current":-7.03444,"twenty":-8.180254,"median":-6.166957,"eighty":-3.621517,"marketCap":2296081191},{"date":"2024-10-10","current":-6.311883,"twenty":-8.160101,"median":-6.193894,"eighty":-3.641637,"marketCap":2046894085},{"date":"2024-10-18","current":-9.026405,"twenty":-8.160101,"median":-6.241014,"eighty":-3.658355,"marketCap":2911929324},{"date":"2024-10-25","current":-10.329157,"twenty":-8.288852,"median":-6.25781,"eighty":-3.667517,"marketCap":3331987588},{"date":"2024-11-01","current":-10.068556,"twenty":-8.453817,"median":-6.28512,"eighty":-3.723447,"marketCap":3250111825},{"date":"2024-11-08","current":-11.890039,"twenty":-8.539495,"median":-6.303819,"eighty":-3.748634,"marketCap":3809002906},{"date":"2024-11-15","current":-12.473246,"twenty":-8.638855,"median":-6.337113,"eighty":-3.770095,"marketCap":3965634801},{"date":"2024-11-22","current":-15.548537,"twenty":-8.857338,"median":-6.401271,"eighty":-3.792036,"marketCap":4941024330},{"date":"2024-11-29","current":-16.918042,"twenty":-8.907392,"median":-6.418623,"eighty":-3.798946,"marketCap":5372620800},{"date":"2024-12-06","current":-17.028741,"twenty":-9.08956,"median":-6.440305,"eighty":-3.809963,"marketCap":5395037855},{"date":"2024-12-13","current":-14.037501,"twenty":-9.184661,"median":-6.496848,"eighty":-3.825885,"marketCap":4438576850},{"date":"2024-12-20","current":-10.693671,"twenty":-9.519989,"median":-6.507224,"eighty":-3.843767,"marketCap":3366294395},{"date":"2024-12-27","current":-10.761363,"twenty":-9.613258,"median":-6.510825,"eighty":-3.853605,"marketCap":3384975274},{"date":"2025-01-03","current":-12.815569,"twenty":-9.789285,"median":-6.563121,"eighty":-3.862906,"marketCap":4035069864},{"date":"2025-01-10","current":-14.889249,"twenty":-9.925093,"median":-6.595306,"eighty":-3.863109,"marketCap":4670219750},{"date":"2025-01-17","current":-11.842286,"twenty":-10.213871,"median":-6.606383,"eighty":-3.864484,"marketCap":3717494921},{"date":"2025-01-24","current":-10.786847,"twenty":-10.358151,"median":-6.624251,"eighty":-3.867614,"marketCap":3407392329},{"date":"2025-01-28","current":-10.88357,"twenty":-10.395234,"median":-6.635203,"eighty":-3.869357,"marketCap":3455962615},{"date":"2025-02-07","current":-10.247352,"twenty":-10.395234,"median":-6.668158,"eighty":-3.877648,"marketCap":3235528242},{"date":"2025-02-14","current":-10.714001,"twenty":-10.679993,"median":-6.721699,"eighty":-3.919404,"marketCap":3381239099},{"date":"2025-02-21","current":-14.934496,"twenty":-10.737429,"median":-6.739573,"eighty":-3.995096,"marketCap":4729998562},{"date":"2025-02-28","current":-14.81818,"twenty":-10.833722,"median":-6.801774,"eighty":-4.034059,"marketCap":4677692101},{"date":"2025-03-07","current":-17.375919,"twenty":-11.045086,"median":-6.869978,"eighty":-4.108477,"marketCap":5507123129},{"date":"2025-03-14","current":-16.002657,"twenty":-11.141514,"median":-6.898274,"eighty":-4.166071,"marketCap":5073726736},{"date":"2025-03-21","current":-15.584553,"twenty":-11.292034,"median":-6.914215,"eighty":-4.215924,"marketCap":4939224407},{"date":"2025-03-28","current":-19.960729,"twenty":-11.418322,"median":-6.958518,"eighty":-4.322429,"marketCap":5432399613},{"date":"2025-04-03","current":-17.71685,"twenty":-11.522026,"median":-7.011873,"eighty":-4.393328,"marketCap":4812194430},{"date":"2025-04-11","current":-14.733536,"twenty":-11.702518,"median":-7.03444,"eighty":-4.445369,"marketCap":3975291051},{"date":"2025-04-17","current":-15.831036,"twenty":-11.83884,"median":-7.042573,"eighty":-4.481028,"marketCap":4281657466}],"updateTime":1744932796184}}}